- 君实生物 (688180)- 非流动负债

按负债周期分类:一年以上到期的非流动负债分析

归母股东权益

64.8亿    ,11.2,33.2,29.8,58.3,79.5,94.8,71.5,64.8
了解明细
少数股东权益

1.3亿    ,-0.0,-0.0,-0.0,-0.0,3.7,2.9,1.7,1.3
了解明细
负债合计

43.8亿    ,1.0,9.4,14.3,21.7,27.2,27.8,40.2,43.8
了解明细
资产合计

109.9亿    ,12.2,42.5,44.1,80.0,110.3,125.6,113.4,109.9
了解明细



流动负债

22.9亿    ,0.6,4.7,5.8,14.7,20.0,17.7,24.4,22.9
20.8%
了解明细
非流动负债

21.0亿    ,0.4,4.7,8.6,7.0,7.2,10.2,15.8,21.0
19.1%
了解明细



长期借款

17.4亿    ,0,1.5,7.4,5.4,4.9,8.4,12.0,17.4
了解明细
应付债券

0亿    ,0,2.4,0,0,0,0,0,0
了解明细
长期应付款

0亿    ,0,0,0,0,0,0,0,0
了解明细
专项应付款

0亿    ,0,0,0,0,0,0,0,0
了解明细
预计负债

0.2亿    ,0,0,0,0.0,0,0,0.3,0.2
了解明细
递延所得税负债

0亿    ,0,0,0,0,0,0,0,0
了解明细
递延收益-非流动负债

1.8亿    ,0.4,0.5,0.6,1.0,1.2,1.2,1.8,1.8
了解明细
其他非流动负债

1.6亿    ,0,0.3,0.3,0.2,0.1,0.1,1.6,1.6
了解明细